XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.16

-3.2%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16429)	11/14/2003 7:59:47 PM
From: aknahow	Read Replies (2) of 17367

Neuprex is one form of BPI and Xoma will do nothing with it on its' own, unless and until probes provide a significant reason to bring it into clinic without a partner. Bpi peptides are something else and I am interested in the acne trial. But since Xoma never told shareholders about Crohn's results, or the Serono trial, I see no reason to rush into Xoma. If the funds have already established a massive position, and the stock has gone down, what happens when they sell? Funds don't know much, not even the importance of being honest. Before they establish a position it is of interest that they might. Once they own it, they are just more potential sellers, either to take profits, or in the case of Xoma, to cut losses. <g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next